New cancer clinical trial: NSE/Alb as a Prognostic Biomarker for Lung Cancer

Published on: October 30, 2018 at 12:00PM
Condition:   Carcinoma, Non-Small-Cell Lung
Intervention:   Diagnostic Test: Neuron-Specific Enolase to Albumin Ratio
Sponsors:   First Affiliated Hospital Xi'an Jiaotong University;   Second Affiliated Hospital of Xi'an Jiaotong University;   Shaanxi Provincial Cancer Hospital;   Shaanxi Provincial People's Hospital;   Xi'an Central Hospital
Recruiting
https://ift.tt/2Q9wAhF